Covid-19 vaccination coverage and break through infections in urban slums of Bengaluru, India: A cross sectional study
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication are distributed under the Creative Commons Attribution 4.0 International license (CC BY 4.0). The rights of the works published in this journal are the property of the author and they are free to distribute and disseminate them, as long as the source is correctly cited.
Main Article Content
Abstract
Background: The world health organization declared Covid-19 as pandemic on 11 March 2020. Vaccinating the people residing in urban overcrowded slums can decrease disease burden and control the Covid-19. Objectives: 1] To estimate COVID 19 vaccination coverage 2] To assess the factors responsible for COVID - 19 vaccination coverage and vaccine hesitancy 3] To study Adverse Events Following Immunization (AEFI) pattern following COVID- 19 vaccination 4] To determine the prevalence of breakthrough infections after COVID - 19 Vaccination in urban slums of Bengaluru, India. Methodology: A community based cross sectional study was conducted in Urban slums belonging to field practice area of Akash Institute of Medical Sciences and Research Centre, Bengaluru, India. After obtaining Institutional ethical clearance, data was collected from 1638 participants and analyzed using SPSS version 24. Chi square test and Fischer’s exact test was applied. Results: In present study, 35.5% (583 out of 1638) of study participants had taken COVID Vaccine of which 533 (91.42%) were partially vaccinated and 50 (8.5%) were fully Vaccinated. 63.65% vaccinated with Covishield reported adverse events and 18.6% with Covaxin. Adverse events were reported by women (74.7%) compared to men (58.6%). Vaccination coverage was high among 18 – 45 years (37.75%), males (64.86%), graduates (95.67%), clerical and skilled workers (70.75%), Upper middle socioeconomic class (72.41%) which was statistically significant. Our study reported break through infections in 7 out of 583 vaccinated with prevalence of 1.2% and was very high among partially vaccinated (85.71%) compared to fully vaccinated individuals (14.28%). Conclusion: The Covid vaccine coverage was low in urban slums. The prevalence of break through infections in our study was higher compared to available data/reports in country. Breakthrough infections was very high among partially vaccinated individuals. The most important factor for vaccine hesitancy is mild or serious adverse effects following immunization which is biggest challenge in global response against pandemic.
References
Russo, A. US and UK Are Optimistic Indicators for COVID-19 Vaccine Uptake;
December, 2020. Available from: https://www.weforum.org/press/2020/12/us-and-uk-are-optimistic-indicators-for-covid-19-vaccine-uptake/. [Last accessed on 2021 Apr 08].
Anwar S, Nasrullah M, Hosen MJ. COVID-19 and Bangladesh: Challenges and How to Address Them. (2020) Front Public Health. 2020; 8:154. Published 2020 Apr 30. https://doi.org/10.3389/fpubh.2020.00154
Al-Mohaithef M, Padhi BK. (2020).Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A WebBased National Survey. J Multidiscip Healthc. Nov 20; 13:1657–1663.
https://doi.org/10.2147/JMDH.S276771
Bode L, Vraga EK. (2015) In related news, that was wrong: The correction of misinformation through related stories functionality in social media. J Commun. 65:619-38.
Colloca L, Miller FG.(2011) The nocebo effect and its relevance for clinical practice. Psychosom Med.73(7):598-603. https://doi.org/10.1097/PSY.0b013e3182294a50
Christian LM, Porter K, Karlsson E, Schultz-Cherry S. (2015). Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination. Vaccine. 33(29):3360-3366. https://doi.org/10.1016/j.vaccine.2015.05.008
COVID -19: Not much difference in breakthrough infections for Covaxin,Covishield. BusinessToday.in [Cited on 2021 Aug 10]. Available from: https://www.businesstoday.in/latest/economy-politics/story/covid-19-not-much-difference-in-breakthrough-infections-for-covaxin-covishield-296443-2021-05-19
Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. (2020) Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults. Ann Intern Med. Dec 15;173(12):964-973.
GAVI, The Vaccine Alliance. What is herd immunity? [cited on 2021 Jun 27]; Available from: https://www.gavi.org/vaccineswork/what-herd-immunity
Government of Karnataka. COVID -19 Information Portal [Cited on 2021 Jul 2]; Available from: https://covid19.karnataka.gov.in/english
Graffigna G, Palamenghi L, Boccia S, Barello S.(2020). Relationship between Citizens' Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis. Vaccines (Basel). Oct 1;8(4):576.
Hervé, C., Laupèze, B., Del Giudice, G. et al.(2019). The how’s and what’s of vaccine reactogenicity. npj Vaccines 4, 39, https://doi.org/10.1038/s41541-019-0132-6
Islam S, Emran GI, Rahman E, Banik R, Sikder T, Smith L, et al. (2020). Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: a Bangladeshi interviewbased survey. J Public Health (Oxf). Oct 15: fdaa182. Epub ahead of print. PMID: 33057666; PMCID: PMC7665690. 11. https://doi.org/10.1093/pubmed/fdaa182
Jennifer S. Chen, Mia Madel Alfajaro, Ryan D. Chow, Jin Wei, Renata B. Filler, Stephanie
C. Eisenbarth, Craig B. Wilen. (2021). Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. Journal of Virology Jan, JVI.00014-21; https://doi.org/10.1128/JVI.00014-21
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A.(2020). A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. Oct 20:1–4.
Malik AA, McFadden SM, Elharake J, Omer SB. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020 Sep; 26:100495. Epub 2020 Aug 12. PMID: 32838242; PMCID: PMC7423333. https://doi.org/10.1016/j.eclinm.2020.100495
Ministry of Health and Family Welfare. Government of India. COVID 19 Vaccination update. [cited on 2021 Jul 27]; Available from: https://mohfw.gov.in
Murphy J., Vallières F., Bentall R.P. et al. (2021). Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun 12, 29 https://doi.org/10.1038/s41467-020-20226-9
Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, Burgess R, Berges BK, Quaye A, Poole BD. (2020). Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). Oct 3;8(4):582.
Polack FP et al. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine December 31, N Engl J Med 2020; 383:2603-2615 https://doi.org/10.1056/NEJMoa2034577
Post N et al. (2020). Antibody response to SARS-CoV-2 infection in humans: A systematic review. PlosOne December 31, 2020 https://doi.org/10.1371/journal.pone.0244126
Reuters. Vaccine ‘Hesitancy’ Rises among Indians as Virus Cases Fall – Survey; December, 2020. Available from: https://reut.rs/3ja1hDu [Last accessed on 2021 Apr 08].
Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet. 2020; 396: 1979–93. https://doi.org/10.1016/S0140- 6736(20)32466-1
Russo, A. US and UK Are Optimistic Indicators for COVID-19 Vaccine Uptake;
December, 2020. Available from: https://www.weforum.org/press/2020/12/us-and-uk-are-optimistic-indicators-for-covid-19-vaccine-uptake/. [Last accessed on 2021 Apr 08].
Saleh E, Moody MA, Walter EB. (2016). Effect of antipyretic analgesics on immune responses to vaccination. Hum Vaccin Immunother. 12(9):2391-2402. https://doi.org/10.1080/21645515.2016.1183077
Sallam M, Dababseh D, Eid H, et al. (2021).High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines (Basel). 9(1):42. Published 2021 Jan 12.
United Nations. Department of Economic and Social Affairs, statistics Division. Sustainable Development Goals Overview. [Cited on 2021 Jun 4]; Available from: https://unstats.un.org/sdgs/report/2019/goal-11/
VivekaRoychowdhury. Surveys Find Increasing Vaccine Hesitancy among Respondents; December, 2020. Available from: https://bit.ly/3DCttIR
World Health Organization. Situation Report – COVID 19. [cited on 2021 Jul 2]; Available from: https://bit.ly/3u9JYsT